Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1049566

registered interest
date	28/01/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Pregnancy: Mental Illness
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government what assessment they have made of whether perinatal mental illnesses are being adequately identified and treated; whether they have made any assessment of the links between (1) perinatal mental illness and emotional and behavioural problems in children, and (2) perinatal mental illness and intergenerational cycles of poverty; whether, as a result of any such assessment, they intend to take steps to tackle any under-identification of perinatal mental illness; and if so, what steps.
tabling member printed	Lord Bird
uin	HL13154
answer	answer is ministerial correction date of answer 11/02/2019 answer text <p>Perinatal mental illness covers a wide range of conditions. Although the Government has made no formal assessment of the links between perinatal mental health and intergenerational poverty, we stated in the Five Year Forward View for Mental Health that if left untreated, it can have significant and long-lasting effects not only on the woman but also on the emotional, social and cognitive development of children.</p><p>The Government is committed to improving both the detection and treatment of perinatal mental illness. General practitioners and primary care teams have a crucial role in supporting the identification and treatment of perinatal mental illness, including post-natal depression, and are part of an integrated pathway of services. Support includes monitoring early onset conditions, providing pre-conception counselling and referring women to specialist mental health services, including Improving Access to Psychological Therapies services and specialist perinatal community teams, if necessary.</p><p>To date, NHS England and Health Education England has also funded training for over 3,000 staff and professionals in mental health, maternity services and primary care to better identify and support women with perinatal mental health needs.</p><p>We are investing £365 million from 2015/16 to 2020/21 in perinatal mental health services to ensure that by 2020/21 at least 30,000 more women each year are able to access evidence-based specialist mental health care during the perinatal period. This investment is designed to improve access to specialist perinatal mental health services across England, resulting in better outcomes for women and their families.</p><p>In addition, the NHS Long Term Plan, includes a commitment for a further 24,000 women to be able to access specialist perinatal mental health care by 2023/24, building on the additional 30,000 women who will access these services each year by 2020/21 under pre-existing plans. Specialist care will also be available from preconception to 24 months after birth, which will provide an extra year of support.</p> answering member printed Baroness Blackwood of North Oxford question first answered 11/02/2019 13:47:54 answering member 4019 label Biography information for Baroness Blackwood of North Oxford
tabling member	4564 label Biography information for Lord Bird

1049571

registered interest
date	28/01/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Surgery: Allergies
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government what assessment they have made of the number of independent healthcare providers who have provided data to the Royal College of Anaesthetists’ national audit project on life-threatening allergic reaction during surgery; and what steps, if any, they intend to take to encourage such providers to provide such data.
tabling member printed	Baroness Finlay of Llandaff
uin	HL13158
answer	answer is ministerial correction date of answer 11/02/2019 answer text <p>We have made no assessment of the number of independent healthcare providers who have provided data to the Royal College of Anaesthetists. We encourage transparency and data sharing in the interest of improving care.</p><p>Private providers providing National Health Service funded services should meet all of the requirements in respect of information governance that we place on NHS organisations and the quality of services would be monitored through the commissioning contract.</p><p>The Paterson Inquiry, which is due to report its conclusions and recommendations in summer 2019, will consider how and when information is shared between the NHS and the independent sector.</p><p> </p> answering member printed Baroness Blackwood of North Oxford question first answered 11/02/2019 17:39:49 answering member 4019 label Biography information for Baroness Blackwood of North Oxford
tabling member	3609 label Biography information for Baroness Finlay of Llandaff

1049572

registered interest
date	28/01/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Hospitals: Private Sector
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government what steps they will take to ensure that patients treated in independent healthcare providers’ hospitals will receive a uniform standard of care; and what steps they will take to ensure that any recommendations on patient care from medical royal colleges are adopted by such providers.
tabling member printed	Baroness Finlay of Llandaff
uin	HL13159
answer	answer is ministerial correction date of answer 11/02/2019 answer text <p>The Care Quality Commission (CQC) is the independent regulator of health and adult social care in England, and is responsible for ensuring that all health and social care services provide people with safe, effective, compassionate, high quality care; and encouraging services to improve. The CQC uses the same assessment framework of key lines of enquiry and ratings characteristics for its inspections and ratings across all healthcare service types, including both National Health Service and independent sector providers.</p><p>Key standards and recommendations on patient care made by medical Royal Colleges are reflected in the CQC’s inspection frameworks and guidance for specific healthcare services, and the CQC reports on where providers are following that guidance.</p> answering member printed Baroness Blackwood of North Oxford question first answered 11/02/2019 13:54:54 answering member 4019 label Biography information for Baroness Blackwood of North Oxford
tabling member	3609 label Biography information for Baroness Finlay of Llandaff

1049579

registered interest
date	28/01/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Liothyronine
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government what discussions they have had, or intend to have, with NHS England on ensuring Liothyronine (T3) is prescribed in accordance with NICE guidelines.
tabling member printed	Lord Hunt of Kings Heath
uin	HL13166
answer	answer is ministerial correction date of answer 11/02/2019 answer text <p>The Department has had no such discussions with NHS England on ensuring liothyronine is prescribed in accordance with the National Institute for Health and Care Excellence guidelines, nor does the Department intend to conduct such an assessment.</p><p>The Regional Medicines Optimising Committee published its latest guidance on the prescribing of liothyronine in November and we can confirm NHS England is working closely with clinical commissioning groups (CCGs) on the prescribing of liothyronine to support them with the implementation of guidance for CCGs on items which should not be routinely prescribed in primary care.</p><p>CCGs are expected to have regard to national guidance, and are responsible for developing their own local approaches to its implementation taking into account local priorities and needs.</p> answering member printed Baroness Blackwood of North Oxford grouped question UIN HL13167 question first answered 11/02/2019 17:39:28 answering member 4019 label Biography information for Baroness Blackwood of North Oxford
tabling member	2024 label Biography information for Lord Hunt of Kings Heath

1049580

registered interest
date	28/01/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Liothyronine
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government whether they intend to conduct an assessment of the impact of the withdrawal of Liothyronine (T3) on patients as a result of Clinical Commissioning Groups misinterpreting or failing to follow NHS England's guidance on the prescription of that drug.
tabling member printed	Lord Hunt of Kings Heath
uin	HL13167
answer	answer is ministerial correction date of answer 11/02/2019 answer text <p>The Department has had no such discussions with NHS England on ensuring liothyronine is prescribed in accordance with the National Institute for Health and Care Excellence guidelines, nor does the Department intend to conduct such an assessment.</p><p>The Regional Medicines Optimising Committee published its latest guidance on the prescribing of liothyronine in November and we can confirm NHS England is working closely with clinical commissioning groups (CCGs) on the prescribing of liothyronine to support them with the implementation of guidance for CCGs on items which should not be routinely prescribed in primary care.</p><p>CCGs are expected to have regard to national guidance, and are responsible for developing their own local approaches to its implementation taking into account local priorities and needs.</p> answering member printed Baroness Blackwood of North Oxford grouped question UIN HL13166 question first answered 11/02/2019 17:39:28 answering member 4019 label Biography information for Baroness Blackwood of North Oxford
tabling member	2024 label Biography information for Lord Hunt of Kings Heath

1049581

registered interest
date	28/01/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Liothyronine
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government what steps they are taking to ensure that Liothyronine (T3) is purchased at a cost in line with other EU countries.
tabling member printed	Lord Hunt of Kings Heath
uin	HL13168
answer	answer is ministerial correction date of answer 11/02/2019 answer text <p>All United Kingdom marketing authorisation holders of liothyronine are obliged to ensure that the product complies with the minimum standard as specified in the updated British Pharmacopoeia monograph for liothyronine tablets. Liothyronine on the market in other European Union Member States may not comply with the updated British Pharmacopoeia monograph and therefore would not be considered therapeutically equivalent.</p><p>Liothyronine is an unbranded generic medicine. The Department encourages competition between suppliers of unbranded generic medicines to keep prices down. This generally works well and has led to some of the lowest prices in Europe. Concerns about anti-competitive behaviour are a matter for the Competition and Markets Authority (CMA) to investigate.</p><p>Liothyronine, marketed by Advanz Pharma (formerly Concordia), is currently the subject of an investigation by the CMA. The CMA has provisionally found that the company abused its dominant position to overcharge the National Health Service by millions of pounds for liothyronine tablets. A provisional decision does not necessarily lead to an infringement decision. Where companies have breached competition law, the Department will seek damages and invest that money back into the NHS.</p> answering member printed Baroness Blackwood of North Oxford question first answered 11/02/2019 13:48:58 answering member 4019 label Biography information for Baroness Blackwood of North Oxford
tabling member	2024 label Biography information for Lord Hunt of Kings Heath

1049587

registered interest
date	28/01/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Social Services
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government when they expect to publish their Green Paper on social care.
tabling member printed	Lord Lipsey
uin	HL13173
answer	answer is ministerial correction date of answer 11/02/2019 answer text <p>The Social Care Green Paper remains a priority for this Government and the Department. We will be publishing the Green Paper at the earliest opportunity.</p> answering member printed Baroness Blackwood of North Oxford question first answered 11/02/2019 13:53:50 answering member 4019 label Biography information for Baroness Blackwood of North Oxford
tabling member	2492 label Biography information for Lord Lipsey

1049589

registered interest
date	28/01/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Genetics
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government who authorised NHS England's scheme to allow people to pay to have their genes sequenced on the condition that they share their data.
tabling member printed	Lord Scriven
uin	HL13175
answer	answer is ministerial correction date of answer 11/02/2019 answer text <p>The second Life Sciences Sector Deal, published by the Government in December 2018, announced that Genomics England will undertake development work on a new service to enable volunteers to pay for a personalised report on their unique genetic makeup.</p><p>Genomics England are in the early stages of developing the scheme, working with patient groups and the public as well as key partners, including the National Health Service.</p><p>It will be developed in line with the founding principles of the NHS and established to the highest ethical standards.</p> answering member printed Baroness Blackwood of North Oxford grouped question UIN HL13176 question first answered 11/02/2019 17:38:56 answering member 4019 label Biography information for Baroness Blackwood of North Oxford
tabling member	4333 label Biography information for Lord Scriven

1049591

registered interest
date	28/01/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Genetics
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government what assessment they have made of the ethics implications of NHS England's scheme to allow people to pay to have their genes sequenced on the condition that they share their data.
tabling member printed	Lord Scriven
uin	HL13176
answer	answer is ministerial correction date of answer 11/02/2019 answer text <p>The second Life Sciences Sector Deal, published by the Government in December 2018, announced that Genomics England will undertake development work on a new service to enable volunteers to pay for a personalised report on their unique genetic makeup.</p><p>Genomics England are in the early stages of developing the scheme, working with patient groups and the public as well as key partners, including the National Health Service.</p><p>It will be developed in line with the founding principles of the NHS and established to the highest ethical standards.</p> answering member printed Baroness Blackwood of North Oxford grouped question UIN HL13175 question first answered 11/02/2019 17:38:57 answering member 4019 label Biography information for Baroness Blackwood of North Oxford
tabling member	4333 label Biography information for Lord Scriven

1049596

registered interest
date	28/01/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Contraceptives
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government whether they intend to monitor and record contraceptive use in the UK once the NHS goes paperless in 2020; and if so, whether they will record types of contraceptives being used according to age group.
tabling member printed	Baroness Tonge
uin	HL13181
answer	answer is ministerial correction date of answer 11/02/2019 answer text <p>Contraception supplied in sexual and reproductive health services in England is monitored and recorded nationally through the Sexual and Reproductive Health Activity Data Set, which includes data on age, consultation medium and contraception main method. The data is collected from all sexual and reproductive health services, including some general practitioner (GP) services, and will continue after the National Health Service goes paperless. Data by age is not collected where contraception is supplied by general practice under the GP Contract.</p> answering member printed Baroness Blackwood of North Oxford question first answered 11/02/2019 13:40:30 answering member 4019 label Biography information for Baroness Blackwood of North Oxford
tabling member	200 label Biography information for Baroness Tonge